American Medical Technologies Inc. (ADLI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2007 | 1.83 Million USD | -10.92% |
| 2006 | 2.06 Million USD | -40.35% |
| 2005 | 3.45 Million USD | -24.94% |
| 2004 | 4.6 Million USD | -42.76% |
| 2003 | 8.05 Million USD | -0.63% |
| 2002 | 8.1 Million USD | -42.92% |
| 2001 | 14.19 Million USD | -22.39% |
| 2000 | 18.29 Million USD | -54.67% |
| 1999 | 40.34 Million USD | -3.6% |
| 1998 | 41.85 Million USD | 85.77% |
| 1997 | 22.53 Million USD | 5.87% |
| 1996 | 21.28 Million USD | 63.7% |
| 1995 | 13 Million USD | 17.12% |
| 1994 | 11.1 Million USD | -10.48% |
| 1993 | 12.4 Million USD | 51.22% |
| 1992 | 8.2 Million USD | -59.8% |
| 1991 | 20.4 Million USD | 158.23% |
| 1990 | 7.9 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2008 Q2 | 1.8 Million USD | 1.15% |
| 2008 Q3 | 1.57 Million USD | -12.97% |
| 2008 Q1 | 1.78 Million USD | -2.66% |
| 2007 Q4 | 1.83 Million USD | -9.57% |
| 2007 Q2 | 2.56 Million USD | 18.26% |
| 2007 FY | 1.83 Million USD | -10.92% |
| 2007 Q1 | 2.16 Million USD | 4.96% |
| 2007 Q3 | 2.03 Million USD | -20.64% |
| 2006 Q2 | 2.64 Million USD | -18.28% |
| 2006 Q3 | 2.11 Million USD | -20.25% |
| 2006 FY | 2.06 Million USD | -40.35% |
| 2006 Q4 | 2.06 Million USD | -2.24% |
| 2006 Q1 | 3.23 Million USD | -6.39% |
| 2005 Q2 | 4.2 Million USD | -7.37% |
| 2005 Q1 | 4.53 Million USD | -1.6% |
| 2005 FY | 3.45 Million USD | -24.94% |
| 2005 Q4 | 3.45 Million USD | -15.18% |
| 2005 Q3 | 4.07 Million USD | -2.92% |
| 2004 Q4 | 4.6 Million USD | -11.23% |
| 2004 Q2 | 5.61 Million USD | -18.3% |
| 2004 Q3 | 5.19 Million USD | -7.51% |
| 2004 Q1 | 6.87 Million USD | -14.66% |
| 2004 FY | 4.6 Million USD | -42.76% |
| 2003 Q1 | 7.24 Million USD | -10.6% |
| 2003 Q3 | 8.74 Million USD | 0.07% |
| 2003 Q4 | 8.05 Million USD | -7.92% |
| 2003 FY | 8.05 Million USD | -0.63% |
| 2003 Q2 | 8.73 Million USD | 20.62% |
| 2002 Q1 | 13.12 Million USD | -7.54% |
| 2002 Q2 | 11.75 Million USD | -10.42% |
| 2002 Q3 | 10.89 Million USD | -7.34% |
| 2002 Q4 | 8.1 Million USD | -25.63% |
| 2002 FY | 8.1 Million USD | -42.92% |
| 2001 Q2 | 15.46 Million USD | -9.64% |
| 2001 Q1 | 17.11 Million USD | -6.43% |
| 2001 Q3 | 15.49 Million USD | 0.18% |
| 2001 Q4 | 14.19 Million USD | -8.37% |
| 2001 FY | 14.19 Million USD | -22.39% |
| 2000 Q4 | 18.29 Million USD | -49.4% |
| 2000 Q1 | 37.43 Million USD | -7.21% |
| 2000 FY | 18.29 Million USD | -54.67% |
| 2000 Q2 | 37.35 Million USD | -0.24% |
| 2000 Q3 | 36.14 Million USD | -3.22% |
| 1999 Q1 | 40.47 Million USD | -3.29% |
| 1999 Q4 | 40.34 Million USD | 1.89% |
| 1999 Q3 | 39.6 Million USD | -4.08% |
| 1999 Q2 | 41.28 Million USD | 2.0% |
| 1999 FY | 40.34 Million USD | -3.6% |
| 1998 Q1 | 24.54 Million USD | 8.92% |
| 1998 FY | 41.85 Million USD | 85.77% |
| 1998 Q4 | 41.85 Million USD | 24.54% |
| 1998 Q3 | 33.6 Million USD | 26.01% |
| 1998 Q2 | 26.67 Million USD | 8.68% |
| 1997 Q3 | 21.97 Million USD | 0.2% |
| 1997 FY | 22.53 Million USD | 5.87% |
| 1997 Q4 | 22.53 Million USD | 2.51% |
| 1997 Q2 | 21.93 Million USD | -1.98% |
| 1997 Q1 | 22.37 Million USD | 5.16% |
| 1996 Q3 | 20.3 Million USD | 47.04% |
| 1996 Q4 | 21.28 Million USD | 4.8% |
| 1996 FY | 21.28 Million USD | 63.7% |
| 1996 Q2 | 13.8 Million USD | 5.42% |
| 1996 Q1 | 13.1 Million USD | 0.77% |
| 1995 FY | 13 Million USD | 17.12% |
| 1995 Q4 | 13 Million USD | 3.17% |
| 1995 Q1 | 11.9 Million USD | 7.21% |
| 1995 Q2 | 11.3 Million USD | -5.04% |
| 1995 Q3 | 12.6 Million USD | 11.5% |
| 1994 Q4 | 11.1 Million USD | -8.26% |
| 1994 Q2 | 14.1 Million USD | 19.49% |
| 1994 Q1 | 11.8 Million USD | -4.84% |
| 1994 Q3 | 12.1 Million USD | -14.18% |
| 1994 FY | 11.1 Million USD | -10.48% |
| 1993 Q4 | 12.4 Million USD | 34.78% |
| 1993 FY | 12.4 Million USD | 51.22% |
| 1993 Q1 | 9.1 Million USD | 10.98% |
| 1993 Q2 | 10.1 Million USD | 10.99% |
| 1993 Q3 | 9.2 Million USD | -8.91% |
| 1992 Q2 | 14.1 Million USD | -4.73% |
| 1992 Q3 | 10 Million USD | -29.08% |
| 1992 Q4 | 8.2 Million USD | -18.0% |
| 1992 FY | 8.2 Million USD | -59.8% |
| 1992 Q1 | 14.8 Million USD | -27.45% |
| 1991 FY | 20.4 Million USD | 158.23% |
| 1991 Q1 | 12.6 Million USD | 59.49% |
| 1991 Q2 | 21.9 Million USD | 73.81% |
| 1991 Q4 | 20.4 Million USD | -10.53% |
| 1991 Q3 | 22.8 Million USD | 4.11% |
| 1990 Q4 | 7.9 Million USD | 0.0% |
| 1990 FY | 7.9 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Ansell Limited | 3.23 Billion USD | 99.943% |
| Ansell Limited | 3.24 Billion USD | 99.943% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | 99.624% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -511.948% |
| Psykey, Inc. | 1.72 Million USD | -6.409% |
| ConvaTec Group Plc | 3.7 Billion USD | 99.95% |
| ConvaTec Group Plc | 3.71 Billion USD | 99.951% |
| Encision Inc. | 3.81 Million USD | 51.766% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -181.963% |
| LifePoint, Inc. | 8.8 Million USD | 79.135% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 88.48% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -105.37% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | 66.514% |
| Reflect Scientific, Inc. | 2.66 Million USD | 31.131% |
| SmileDirectClub, Inc. | 597.06 Million USD | 99.692% |
| Sector 10, Inc. | 1000.00 USD | -183706.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 99.961% |
| SheerVision, Inc. | 837.56 Thousand USD | -119.453% |
| United Health Products, Inc. | 284.64 Thousand USD | -545.742% |
| Vasamed, Inc. | 1.6 Million USD | -14.861% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -723.603% |
| Yubo International Biotech Limited | 2.34 Million USD | 21.736% |